Greenwich LifeSciences, Inc. (GLSI) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $6.18M | +51.0% |
| 2024 | $4.09M | -41.5% |
| 2023 | $6.99M | -48.1% |
| 2022 | $13.47M | -50.5% |
| 2021 | $27.20M | -5.1% |
| 2020 | $28.66M | +419217.8% |
| 2019 | $6.8K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $6.18M | +51.0% |
| 2024 | $4.09M | -41.5% |
| 2023 | $6.99M | -48.1% |
| 2022 | $13.47M | -50.5% |
| 2021 | $27.20M | -5.1% |
| 2020 | $28.66M | +419217.8% |
| 2019 | $6.8K | — |